Nicolas Jansen
University of Liège, Centre Hospitalier Universitaire de Liège
Papers
5
Total Citations
79
H-Index
4
About
Nicolas Jansen is a radiation oncology researcher whose work centers on stereotactic body radiotherapy (SBRT) and robotic radiosurgery, with a particular focus on the CyberKnife® system as a precise, minimally invasive treatment modality. His research has made meaningful contributions to the clinical management of oligorecurrent and metastatic disease, demonstrating the efficacy and safety of robotic SBRT for challenging anatomical sites including the lungs and liver. His 2020 study on oligorecurrent pulmonary metastases and his 2017 investigation of hepatic oligorecurrence together represent landmark clinical evaluations of CyberKnife SBRT in metastatic settings, collectively garnering over 40 citations and helping to establish evidence-based protocols for these patient populations. His broader outcomes analysis of 130 patients with primary and secondary lung tumors further solidified CyberKnife SBRT's role across a spectrum of thoracic malignancies. Beyond clinical outcomes, Jansen has contributed to the technical rigor of the field through dosimetric commissioning work, including the validation of Monte Carlo algorithms for robotic radiosurgery. Early in his career, he also explored CyberKnife applications for benign pathologies, reflecting the breadth of his investigative curiosity in advancing non-invasive radiotherapy options.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5[Cyberknife and benign pathologies].2 citations · 2011